Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.
Winter 2021/2022

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Imuldosa Approved as Stelara® Biosimilar

This drug has been approved for the treatment of multiple chronic inflammatory disorders.
Nov 2024

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.
Nov 2024

Are Migraine Drugs Driving Up Pharmacy Spend?

Recent data from CWCI and WCRI, plus clinical concerns.
Nov 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 15 16 17 18 19 27

Whitepapers

lockmap-markermagnifiercrossmenucross-circle